Cytokine Profile of Children Hospitalized with Virologically-Confirmed Dengue during Two Phase III Vaccine Efficacy Trials

BACKGROUND: Two large-scale efficacy studies with the recombinant yellow fever-17D–dengue virus, live-attenuated, tetravalent dengue vaccine (CYD-TDV) candidate undertaken in Asia (NCT01373281) and Latin America (NCT01374516) demonstrated significant protection against dengue disease during two year...

Descripción completa

Detalles Bibliográficos
Autores principales: Harenberg, Anke, de Montfort, Aymeric, Jantet-Blaudez, Frédérique, Bonaparte, Matthew, Boudet, Florence, Saville, Melanie, Jackson, Nicholas, Guy, Bruno
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4961416/
https://www.ncbi.nlm.nih.gov/pubmed/27459266
http://dx.doi.org/10.1371/journal.pntd.0004830

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4961416/
https://www.ncbi.nlm.nih.gov/pubmed/27459266
http://dx.doi.org/10.1371/journal.pntd.0004830

Ejemplares similares